Medscape Medical News - FDA Approvals
- Alert FDA Approves New Antibiotic for Uncomplicated UTIs
- Alert FDA Approves Second Gene Therapy for Hemophilia B
- Alert Europe Approves Paroxysmal Nocturnal Hemoglobinuria Drug
- Alert FDA Approves New Bladder Cancer Drug
- Alert Alectinib Approved for ALK-Positive Adjuvant NSCLC
- Alert FDA OKs Sub-Q Vedolizumab for Crohn's Maintenance Therapy
- Alert FDA Approves Second Ustekinumab Biosimilar
- Alert FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
- Alert Abecma Approved for Earlier Lines in R/R Multiple Myeloma
- Alert FDA Approves First Prescription App for Depression
- Alert FDA Approves Iloperidone for Bipolar Disorder
- Alert FDA Clears TriClip for Tricuspid Regurgitation
- FDA OKs Danicopan for Extravascular Hemolysis in PNH
- Alert FDA OKs First-in-Class Sotatercept for PAH
- Alert FDA Clears Ravulizumab for Neuromyelitis Optica
- Alert FDA Grants Mirvetuximab Full Approval for Ovarian Cancer
- Alert FDA Expands Indications for Bempedoic Acid in CVD Prevention
- Alert FDA OKs Givinostat for Duchenne Muscular Dystrophy
- Alert FDA Okays New Drug for Resistant Hypertension
- Alert FDA Expands Approval of Treatment for GPP
- Alert FDA Investigates Secondary Cancers From CAR T-Cell Therapies
- Alert FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia
- Alert FDA Approves Nirogacestat for Desmoid Tumors
- Alert FDA OKs Symplicity Renal Denervation System for Hypertension
- Alert FDA Expands Enzalutamide Approval to Earlier Prostate Cancer
- Alert FDA OKs First-Line Pembro With Chemo for Gastric/GEJ Cancer
- Alert FDA OKs Capivasertib for Certain Advanced Breast Cancers
- Alert FDA Approves Repotrectinib for ROS1-Positive NSCLC
- Alert FDA Approves First Drug for Rare, Deadly Clotting Disorder
- FDA Amends Pembrolizumab Indication in Gastric Cancer
- Alert FDA Approves Fruquintinib for Metastatic Colorectal Cancer
- FDA OKs Paradise Renal Denervation System for Hypertension
- Alert FDA OKs New Treatment for Erosive Esophagitis
- Alert FDA Approves First Ustekinumab Biosimilar
- FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis
- Alert FDA Approves Toripalimab for Nasopharyngeal Carcinoma
- Alert FDA Clears First OTC Fentanyl Urine Test
- Alert FDA Approves Mirikizumab for Ulcerative Colitis
- Alert FDA Okays Drug for Duchenne Muscular Dystrophy
- Alert FDA OKs Ivosidenib for IDH1-mutated Myelodysplastic Syndromes